The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms......
'Its efficacy is 97.6 per cent.' Morepen India Chairman and Managing Director Sushil Suri in an interview with Uddalok Bhattacharya says the Sputnik V vaccine it is manufacturing in India......
The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products. IMAGE:......
Morepen Laboratories has filed a suit before the Delhi high court against the Swiss-based DiaMed Scientific Laboratories, seeking an order restraining the latter from appointing any other dealer in......
Indian drugmaker Morepen Laboratories Ltd has filed an international patent for the manufacturing process of Desloratadine, the Bombay Stock Exchange said on Wednesday.The company is also working......
Morepen Laboratories expects revenues and net to rise by $20 million (Rs 1000 million) and $10-12 million (Rs 500-600 million) respectively, enhanced by a 180-day marketing exclusivity granted to......
Morepen Laboratories on Thursday told the Company Law Board that it was in advanced stages of negotiations with a foreign investor who would bring in Rs 60 crore (Rs 600 million), part of which......
The Company Law Board on Tuesday gave Morepen Laboratories a final reprieve of a few more days to reply on the status of repayment of overdue fixed deposits.The CLB has asked the company to file......